MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 34 filers reported holding MILESTONE PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,434,767 | +9.3% | 462,828 | +0.5% | 0.17% | -17.2% |
| Q2 2023 | $1,312,186 | -27.7% | 460,416 | 0.0% | 0.21% | -49.3% |
| Q1 2023 | $1,814,039 | -0.5% | 460,416 | 0.0% | 0.41% | -6.4% |
| Q4 2022 | $1,823,248 | -85.6% | 460,416 | -66.5% | 0.44% | -82.5% |
| Q3 2022 | $12,627,000 | +33.5% | 1,373,916 | -13.7% | 2.52% | +45.9% |
| Q2 2022 | $9,455,000 | -23.6% | 1,591,822 | -17.5% | 1.72% | +5.9% |
| Q1 2022 | $12,383,000 | +8.0% | 1,928,752 | +10.2% | 1.63% | -4.7% |
| Q4 2021 | $11,464,000 | +14.7% | 1,750,043 | 0.0% | 1.71% | +142.6% |
| Q3 2021 | $9,993,000 | -8.3% | 1,750,043 | -11.6% | 0.70% | -20.1% |
| Q2 2021 | $10,893,000 | +2.4% | 1,980,400 | +7.8% | 0.88% | +146.1% |
| Q1 2021 | $10,633,000 | -13.6% | 1,836,545 | 0.0% | 0.36% | -34.1% |
| Q4 2020 | $12,305,000 | -3.6% | 1,836,545 | +5.3% | 0.54% | -41.2% |
| Q3 2020 | $12,764,000 | – | 1,743,545 | – | 0.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 2,530,585 | $16,955,000 | 0.73% |
| Ikarian Capital, LLC | 1,836,545 | $12,305,000 | 0.54% |
| Boxer Capital, LLC | 2,477,194 | $16,597,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,315,102 | $28,911,000 | 0.48% |
| RA Capital Management | 2,327,714 | $15,596,000 | 0.22% |
| Orbimed Advisors | 2,493,109 | $16,704,000 | 0.15% |
| PURA VIDA INVESTMENTS, LLC | 450,000 | $3,015,000 | 0.11% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 851,291 | $5,704,000 | 0.08% |
| Anson Funds Management LP | 50,113 | $336,000 | 0.07% |
| Tekla Capital Management LLC | 253,610 | $1,699,000 | 0.06% |